Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD

OBJECTIVES: This study aimed to compare the effects of angiotensin-converting-enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) on the risk of pneumonia and severe exacerbations in patients with COPD. PATIENTS AND METHODS: All patients with COPD who used ACEis and ARBs for >90 da...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Lai, Chih-Cheng, Wang, Ya-Hui, Wang, Cheng-Yi, Wang, Hao-Chien, Yu, Chong-Jen, Chen, Likwang
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846309/
https://ncbi.nlm.nih.gov/pubmed/29563786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S158634
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars